Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tranexamic Acid in Soft Tissue Plastic Surgery
2023-510381-28-01Phase 4Authorised
- Sponsor
- St. Olavs University Hospital
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 4, randomised, double-blind trial in postoperative hemorrhage, surgical site infection (SSI), Suture rupture (SWD) and 2 more comparing Topical tranexamic acid with Topical placebo (2 arms). Primary endpoint: Postoperative re-bleeding within 10 days. Planned start Jun 2024; status: authorised.
02
Drugs
tranexamic acid
03
Conditions
postoperative hemorrhagesurgical site infection (SSI)Suture rupture (SWD)Seromathromboembolism
Beyond the preview
Go deeper on 2023-510381-28-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-510381-28-01.